Conmed (CNMD) Invested Capital (2010 - 2026)

Conmed (CNMD) has 17 years of Invested Capital data on file, last reported at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital rose 8.17% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $1.1 billion (up 8.17% YoY), and the FY2025 full-year result was $1.1 billion, up 11.45% from the prior year.
• Invested Capital for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
• Across five years, Invested Capital topped out at $1.1 billion in Q4 2025 and bottomed at $673.0 million in Q2 2022.
• The 5-year median for Invested Capital is $962.7 million (2024), against an average of $929.9 million.
• The widest annual swing landed in 2022, when Invested Capital tumbled 31.09%; it then gained 27.97% in 2024.
• A 5-year view of Invested Capital shows it stood at $815.5 million in 2022, then rose by 16.28% to $948.3 million in 2023, then grew by 1.52% to $962.7 million in 2024, then gained by 11.45% to $1.1 billion in 2025, then declined by 1.44% to $1.1 billion in 2026.
• The last three Invested Capital figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison